TY - JOUR
T1 - Synthesis, antileishmanial activity and cytotoxicity of 2,3-diaryl- and 2,3,8-trisubstituted imidazo[1,2-a]pyrazines
AU - Marchand, Pascal
AU - Bazin, Marc Antoine
AU - Pagniez, Fabrice
AU - Rivière, Guillaume
AU - Bodero, Lizeth
AU - Marhadour, Sophie
AU - Nourrisson, Marie Renée
AU - Picot, Carine
AU - Ruchaud, Sandrine
AU - Bach, Stéphane
AU - Baratte, Blandine
AU - Sauvain, Michel
AU - Pareja, Denis Castillo
AU - Vaisberg, Abraham J.
AU - Le Pape, Patrice
N1 - Publisher Copyright:
© 2015 Elsevier Masson SAS.
PY - 2015/10/20
Y1 - 2015/10/20
N2 - A series of original 2-phenyl-3-(pyridin-4-yl)imidazo[1,2-a]pyrazines and the 3-iodo precursors, bearing a polar moiety at the C-8 position, was synthesized and evaluated for their antileishmanial activities. Two derivatives exhibited very good activity against the promastigote and the amastigote forms of Leishmania major in the micromolar to submicromolar ranges, coupled with a low cytotoxicity against macrophages and 3T3 mouse fibroblast cells. Through LmCK1 inhibition assay, investigations of the putative molecular target of these promising antileishmanial compounds will be discussed.
AB - A series of original 2-phenyl-3-(pyridin-4-yl)imidazo[1,2-a]pyrazines and the 3-iodo precursors, bearing a polar moiety at the C-8 position, was synthesized and evaluated for their antileishmanial activities. Two derivatives exhibited very good activity against the promastigote and the amastigote forms of Leishmania major in the micromolar to submicromolar ranges, coupled with a low cytotoxicity against macrophages and 3T3 mouse fibroblast cells. Through LmCK1 inhibition assay, investigations of the putative molecular target of these promising antileishmanial compounds will be discussed.
KW - Antileishmanial activity
KW - Casein kinase 1
KW - Direct arylation
KW - Imidazo[1 2-a]pyrazines
UR - https://www.scopus.com/pages/publications/84941651532
U2 - 10.1016/j.ejmech.2015.09.002
DO - 10.1016/j.ejmech.2015.09.002
M3 - Artículo
C2 - 26383125
AN - SCOPUS:84941651532
SN - 0223-5234
VL - 103
SP - 381
EP - 395
JO - European Journal of Medicinal Chemistry
JF - European Journal of Medicinal Chemistry
ER -